These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
622 related articles for article (PubMed ID: 29874997)
1. Pathological Roles of Iron in Cardiovascular Disease. Kobayashi M; Suhara T; Baba Y; Kawasaki NK; Higa JK; Matsui T Curr Drug Targets; 2018; 19(9):1068-1076. PubMed ID: 29874997 [TBL] [Abstract][Full Text] [Related]
2. The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection. Ravingerová T; Kindernay L; Barteková M; Ferko M; Adameová A; Zohdi V; Bernátová I; Ferenczyová K; Lazou A Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114290 [TBL] [Abstract][Full Text] [Related]
3. Ferroptosis as a novel therapeutic target for cardiovascular disease. Wu X; Li Y; Zhang S; Zhou X Theranostics; 2021; 11(7):3052-3059. PubMed ID: 33537073 [TBL] [Abstract][Full Text] [Related]
4. Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A. Ishimaru K; Ikeda M; Miyamoto HD; Furusawa S; Abe K; Watanabe M; Kanamura T; Fujita S; Nishimura R; Toyohara T; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H; Ide T J Am Heart Assoc; 2024 Jan; 13(1):e031219. PubMed ID: 38158218 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Baba Y; Higa JK; Shimada BK; Horiuchi KM; Suhara T; Kobayashi M; Woo JD; Aoyagi H; Marh KS; Kitaoka H; Matsui T Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H659-H668. PubMed ID: 29127238 [TBL] [Abstract][Full Text] [Related]
7. Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries. Han X; Zhang J; Liu J; Wang H; Du F; Zeng X; Guo C Apoptosis; 2023 Feb; 28(1-2):108-123. PubMed ID: 36474078 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment. Zhang T; Deng W; Deng Y; Liu Y; Xiao S; Luo Y; Xiang W; He Q Biomed Pharmacother; 2023 Sep; 165():114706. PubMed ID: 37400352 [TBL] [Abstract][Full Text] [Related]
10. Persistent Microvascular Obstruction After Myocardial Infarction Culminates in the Confluence of Ferric Iron Oxide Crystals, Proinflammatory Burden, and Adverse Remodeling. Kali A; Cokic I; Tang R; Dohnalkova A; Kovarik L; Yang HJ; Kumar A; Prato FS; Wood JC; Underhill D; Marbán E; Dharmakumar R Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903536 [TBL] [Abstract][Full Text] [Related]
11. Hemorrhage promotes chronic adverse remodeling in acute myocardial infarction: a T Assimopoulos S; Shie N; Ramanan V; Qi X; Barry J; Strauss BH; Wright GA; Ghugre NR NMR Biomed; 2021 Jan; 34(1):e4404. PubMed ID: 32875632 [TBL] [Abstract][Full Text] [Related]
12. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction. Poulsen SH Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125 [TBL] [Abstract][Full Text] [Related]
13. Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition: a cardiovascular magnetic resonance study with ex vivo validation. Kali A; Kumar A; Cokic I; Tang RL; Tsaftaris SA; Friedrich MG; Dharmakumar R Circ Cardiovasc Imaging; 2013 Mar; 6(2):218-28. PubMed ID: 23403335 [TBL] [Abstract][Full Text] [Related]
14. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model. Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665 [TBL] [Abstract][Full Text] [Related]
15. Molecular therapy of cardiac ischemia-reperfusion injury based on mitochondria and ferroptosis. Wang R; Chen X; Li X; Wang K J Mol Med (Berl); 2023 Sep; 101(9):1059-1071. PubMed ID: 37505243 [TBL] [Abstract][Full Text] [Related]
16. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights. Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700 [TBL] [Abstract][Full Text] [Related]
17. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317 [TBL] [Abstract][Full Text] [Related]
18. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Fang X; Ardehali H; Min J; Wang F Nat Rev Cardiol; 2023 Jan; 20(1):7-23. PubMed ID: 35788564 [TBL] [Abstract][Full Text] [Related]
19. New Insights into the Role of Ferroptosis in Cardiovascular Diseases. Fratta Pasini AM; Stranieri C; Busti F; Di Leo EG; Girelli D; Cominacini L Cells; 2023 Mar; 12(6):. PubMed ID: 36980208 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development. Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]